PS
BSX icon

PayPay Securities’s Boston Scientific BSX Stock Holding History

PayPay Securities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
260
+227
+688% +$12.3K 0.27% 63
2026
Q1 		$2.09K Sell
33
-11
-25% -$880 0.07% 172
2025
Q4 		$4.2K Buy
44
+8
+22% +$784 0.12% 125
2025
Q3 		$3.51K Buy
36
+9
+33% +$932 0.13% 114
2025
Q2 		$2.9K Sell
27
-3
-10% -$304 0.14% 104
2025
Q1 		$3.06K Sell
30
-9
-23% -$906 0.18% 117
2024
Q4 		$3.48K Sell
39
-2
-5% -$176 0.15% 115
2024
Q3 		$3.44K Sell
41
-7
-15% -$552 0.31% 77
2024
Q2 		$3.7K Sell
48
-13
-21% -$952 0.31% 82
2024
Q1 		$4.18K Sell
61
-26
-30% -$1.67K 0.21% 99
2023
Q4 		$5.04K Buy
87
+16
+23% +$854 0.25% 88
2023
Q3 		$3.75K Hold
71
– – 0.17% 109
2023
Q2 		$3.84K Sell
71
-28
-28% -$1.46K 0.24% 61
2023
Q1 		$4.95K Sell
99
-54
-35% -$2.54K 0.33% 60
2022
Q4 		$7.08K Buy
+153
New +$6.63K 0.48% 54

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PayPay Securities's BSX Position: Q2 2026 in Review

PayPay Securities increased its Boston Scientific (BSX) stake by 688% in Q2 2026, buying an estimated $12.3K and bringing the position to 260 shares worth $11.1K. The position accounts for 0.27% of the portfolio, ranked #63.

PayPay Securities first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PayPay Securities held 260 shares of Boston Scientific worth $11.1K as of Q2 2026.
  • PayPay Securities bought 227 Boston Scientific shares in Q2 2026, an estimated $12.3K.
  • Boston Scientific made up 0.27% of PayPay Securities's portfolio in Q2 2026, its #63 holding.
  • PayPay Securities first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.